ES8602631A1 - Procedimiento de producir compuestos para tratar la hipertension - Google Patents

Procedimiento de producir compuestos para tratar la hipertension

Info

Publication number
ES8602631A1
ES8602631A1 ES531077A ES531077A ES8602631A1 ES 8602631 A1 ES8602631 A1 ES 8602631A1 ES 531077 A ES531077 A ES 531077A ES 531077 A ES531077 A ES 531077A ES 8602631 A1 ES8602631 A1 ES 8602631A1
Authority
ES
Spain
Prior art keywords
antihypertensives
substituted dipeptides
dipeptides
substituted
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES531077A
Other languages
English (en)
Other versions
ES531077A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES8602631A1 publication Critical patent/ES8602631A1/es
Publication of ES531077A0 publication Critical patent/ES531077A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO DE PRODUCIR COMPUESTOS PARA TRATAR LA HIPERTENSION. CONSISTE EN CONDENSAR UN ACIDO DE FORMULA (II) CON UN COMPUESTO AMINO DE FORMULA (III) EN PRESENCIA DE HALUROS DE ACILO, ANHIDRIDOS MIXTOS O ALQUILESTERES INFERIORES, EN ACETONITRILO, DIOXANO O CLORURO DE METILENO, EN PRESENCIA DE TRIMETILAMINA, PIRIDINA O PICOLINAS, Y A UNA TEMPERATURA ENTRE 0C Y LA TEMPERATURA DE REFLUJO DEL SISTEMA DE REACCION, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. SIENDO: A1 Y A2, H, HAL, HIDROXI Y OTROS, Q FENILO O ARILCICLOALQUILO FUSIONADO; Y E Y2 -OR O UN RADICAL DE FORMULA (IV); R1 Y R2, R, CICLOALQUILO Y OTROS; Z1, Z2 Y Z3 -(CH2)N, -NHCH2(CH2)N- Y OTROS; M1, M2 Y M3, H, ALQUILO, ARILO Y OTROS; M 0 A 3; Y N 0 A 6.
ES531077A 1983-03-16 1984-03-16 Procedimiento de producir compuestos para tratar la hipertension Granted ES531077A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47580483A 1983-03-16 1983-03-16

Publications (2)

Publication Number Publication Date
ES8602631A1 true ES8602631A1 (es) 1985-12-16
ES531077A0 ES531077A0 (es) 1985-12-16

Family

ID=23889224

Family Applications (2)

Application Number Title Priority Date Filing Date
ES531077A Granted ES531077A0 (es) 1983-03-16 1984-03-16 Procedimiento de producir compuestos para tratar la hipertension
ES545175A Expired ES8704875A1 (es) 1983-03-16 1985-06-28 Procedimiento de producir compuestos para tratar la hiper- tension

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES545175A Expired ES8704875A1 (es) 1983-03-16 1985-06-28 Procedimiento de producir compuestos para tratar la hiper- tension

Country Status (11)

Country Link
EP (1) EP0121830A3 (es)
JP (1) JPS59181247A (es)
KR (1) KR840009072A (es)
AU (1) AU2580184A (es)
DK (1) DK156484A (es)
ES (2) ES531077A0 (es)
FI (1) FI841052A (es)
IL (1) IL71266A0 (es)
NO (1) NO841024L (es)
NZ (1) NZ207531A (es)
ZA (1) ZA841981B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482544A (en) * 1982-11-29 1984-11-13 Usv Pharmaceutical Corporation Compounds for treating hypertension
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
EP0127124A3 (en) * 1983-05-23 1987-04-08 Usv Pharmaceutical Corporation Compounds for treating hypertension
DE3588094T2 (de) * 1984-09-12 1996-08-22 Rhone Poulenc Rorer Pharma Antihypertensive Derivate
WO1987001707A1 (en) * 1985-09-16 1987-03-26 Schering Corporation Antihypertensive agents, pharmaceutical compositions containing them and processes for the preparation of the agents and compositions
DE3569368D1 (en) * 1984-11-30 1989-05-18 Fisons Plc Angiotensin converting enzyme inhibitors and their production and use as pharmaceuticals
FR2578544A1 (en) * 1985-03-11 1986-09-12 Usv Pharma Corp Antihypertension spirocyclic compounds
FR2578543B1 (fr) * 1985-03-11 1988-06-10 Usv Pharma Corp Composes spiro-amidoamino anti-hypertenseurs
AR033048A1 (es) 2001-03-19 2003-12-03 Kaneka Corp Metodo para la purificacion de la n-(1(s)-etoxicarbonil-3-fenilpropil) -l-alanina
CN105001139B (zh) * 2015-07-08 2018-03-02 南京葆赫生物技术有限公司 一种抗高血压活性肽、其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3177311D1 (de) * 1980-08-30 1994-06-09 Hoechst Ag Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung.
GR75019B (es) * 1980-09-17 1984-07-12 Univ Miami
DE19575012I2 (de) * 1980-10-23 2002-01-24 Schering Corp Carboxyalkyl-Dipeptide Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
IN156096B (es) * 1981-03-19 1985-05-11 Usv Pharma Corp
GR78413B (es) * 1981-12-29 1984-09-27 Hoechst Ag
EP0083923B1 (en) * 1982-01-11 1988-10-19 Merck & Co. Inc. Aminoacyl-containing dipeptide derivatives useful as antihypertensives
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3210496A1 (de) * 1982-03-23 1983-10-06 Hoechst Ag Neue derivate bicyclischer aminsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung
DE3211676A1 (de) * 1982-03-30 1983-10-06 Hoechst Ag Neue derivate von cycloalka (c) pyrrol-carbonsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue cycloalka (c) pyrrol-carbonsaeuren als zwischenstufen und verfahren zu deren herstellung
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3315464A1 (de) * 1983-04-28 1984-10-31 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern

Also Published As

Publication number Publication date
FI841052A0 (fi) 1984-03-15
ES531077A0 (es) 1985-12-16
IL71266A0 (en) 1984-06-29
DK156484A (da) 1984-09-17
JPS59181247A (ja) 1984-10-15
ES545175A0 (es) 1987-05-01
EP0121830A3 (en) 1986-02-05
DK156484D0 (da) 1984-03-15
FI841052A (fi) 1984-09-17
EP0121830A2 (en) 1984-10-17
NO841024L (no) 1984-09-17
ES8704875A1 (es) 1987-05-01
KR840009072A (ko) 1984-12-24
ZA841981B (en) 1984-10-31
NZ207531A (en) 1986-12-05
AU2580184A (en) 1984-09-20

Similar Documents

Publication Publication Date Title
ATE75743T1 (de) Hydrazinderivate und ihre verwendung.
ES8700262A1 (es) Un compuesto
ES8602631A1 (es) Procedimiento de producir compuestos para tratar la hipertension
ES466850A1 (es) Procedimiento para la preparacion de 2-bromo-6-fluor-n-imi- dazolidinilidenbenzamina.
ES8609364A1 (es) Procedimiento de preparar derivados antihipertensivos
AU560330B2 (en) Substituted l-alanyl antihypertensive
EP0127124A3 (en) Compounds for treating hypertension
AU2176183A (en) Dipeptides for treating hypertension
ES8602021A1 (es) Procedimiento de preparar compuestos espirociclicos antihi- pertensivos
AU562643B2 (en) N-arylpiperazine derivatives
EP0127090A3 (en) Angiotensin-converting enzyme inhibitors
EP0153755A3 (en) Compounds for treating hypertension
ES8606259A1 (es) Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo.
ES8505363A1 (es) Un procedimiento para preparar una 3-(2-furoil)-5-2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridina
ES8102122A1 (es) Un procedimiento para obtener derivados de quinazolina
ATE54912T1 (de) Mevalonolactonaehnliche imidazole und derivate.
ES8701751A1 (es) Un metodo de preparar un derivado de n-(piridina sustituida en posicion 6)-2-carbonil-histidina sustituida en posicion 3
AP2001002047A0 (en) Isoquinoliness as urokinase inhibitors.